https://ift.tt/2IVHF6y

HDFC Securities has 'buy' rating on Sun Pharma with a 12-month target price of Rs 545 as the brokerage expects a recovery in the profitability (24 per cent margin) by FY21E.

from Markets https://ift.tt/2zuAICe

Comments

Popular posts from this blog

MPL accuses ASCI of 'tampering' with ads